Synthesis of a novel PEGylated colon-specific azo-based 4- aminosalicylic acid prodrug
<em><strong>Objective(s):</strong></em> 4-aminosalicylic acid (4-ASA) is an isomer of mesalazine that has recently been shown to be effective against inflammatory bowel disease (IBD), and more specifically, ulcerative colitis. However, the majority of orally administered 4-AS...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2020-06-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | http://ijbms.mums.ac.ir/article_15505_e48256dd8798fffbcd0c469a04d4ac20.pdf |